Optimal Levetiracetam Dosing in Neurological ICU Patients With Augmented Renal Clearance – PubMed Black Hawk Supplements
BLACK HAWK: Most trusted shilajit supplement for immune system
Published article
No abstract
Black Hawk Supplements, best supplements in the UK
. 2024 Aug 1;52(8):e431-e432.
doi: 10.1097/CCM.0000000000006288. Epub 2024 Jul 15.
Affiliations
- PMID: 39007579
- DOI: 10.1097/CCM.0000000000006288
Optimal Levetiracetam Dosing in Neurological ICU Patients With Augmented Renal Clearance
Patrick M Honore et al. Crit Care Med. .
No abstract available
Conflict of interest statement
The authors have disclosed that they do not have any potential conflicts of interest.
Similar articles
-
Zhang Y, Zhang Q, Zhang J. Zhang Y, et al. Pharmacotherapy. 2024 May;44(5):409-410. doi: 10.1002/phar.2918. Pharmacotherapy. 2024. PMID: 38853609 No abstract available.
-
Price L, Garrity L, Stiehl S. Price L, et al. Pharmacotherapy. 2024 May;44(5):411-412. doi: 10.1002/phar.2919. Pharmacotherapy. 2024. PMID: 38853603 No abstract available.
-
Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients.
Spencer DD, Jacobi J, Juenke JM, Fleck JD, Kays MB. Spencer DD, et al. Pharmacotherapy. 2011 Oct;31(10):934-41. doi: 10.1592/phco.31.10.934. Pharmacotherapy. 2011. PMID: 21950640 Clinical Trial.
-
Levetiracetam in the management of epilepsy.
Leach JP. Leach JP. Hosp Med. 2004 Dec;65(12):740-4. doi: 10.12968/hosp.2004.65.12.740. Hosp Med. 2004. PMID: 15624450 Review.
-
Preliminary efficacy of levetiracetam in children.
Glauser TA, Dulac O. Glauser TA, et al. Epileptic Disord. 2003 May;5 Suppl 1:S45-50. Epileptic Disord. 2003. PMID: 12915341 Review.
References
-
- Valdes E, Fang T, Boffa M, et al.: Optimal dosing of levetiracetam for seizure prophylaxis in critically ill patients: A prospective observational study. Crit Care Med. 2024; 52:e1–e10
-
- Sime FB, Roberts JA, Jeffree RL, et al.: Population pharmacokinetics of levetiracetam in patients with traumatic brain injury and subarachnoid hemorrhage exhibiting augmented renal clearance. Clin Pharmacokinet. 2021; 60:655–664
-
- Udy AA, Roberts JA, Shorr AF, et al.: Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: Identifying at-risk patients. Crit Care. 2013; 17:R35
-
- Johannessen SI, Battino D, Berry DJ, et al.: Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit. 2003; 25:347–363
-
- Hobbs AL, Shea KM, Roberts KM, et al.: Implications of augmented renal clearance on drug dosing in critically ill patients: A focus on antibiotics. Pharmacotherapy. 2015; 35:1063–1075
Publication types
MeSH terms
Substances
BLACK HAWK: Best ashwagandha supplement for teens
Read the original publication:
Optimal Levetiracetam Dosing in Neurological ICU Patients With Augmented Renal Clearance – PubMed